<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-11-05-b</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-11-1-9</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Attention Deficit Disorders</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>ADHD and Psychoactive Substance Abuse</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>01</month>
<year>1997</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>05</month>
<year>2016</year>
</pub-date>
<volume>11</volume>
<issue>1</issue>
<fpage>5</fpage>
<lpage>6</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 1997 The Author(s)</copyright-statement>
<copyright-year>1997</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1097/00004583-199701000-00013" vol="36" page="21">
<article-title>Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>The effect of attention-deficit hyperactivity disorder (ADHD) compared to psychiatric comorbidity, familiality, and adversity, as risk factors for psychoactive substance use disorder (PSUD) was evaluated at the Department of Psychiatry, Massachusetts General Hospital, Boston, MA.</p>
</abstract>
<kwd-group>
<kwd>Attention-Deficit Hyperactivity Disorder</kwd>
<kwd>Psychoactive Substance Use Disorder</kwd>
<kwd>Conduct Disorders</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>The effect of attention-deficit hyperactivity disorder (ADHD) compared to psychiatric comorbidity, familiality, and adversity, as risk factors for psychoactive substance use disorder (PSUD) was evaluated at the Department of Psychiatry, Massachusetts General Hospital, Boston, MA. Using baseline and 4-year follow-up data from 140 ADHD and 120 normal control subjects, the rates of alcohol or drug abuse or dependence (PSUD) were 15%, with no differences between groups. Conduct and bipolar disorders were predictive of PSUD, but these associations were independent of ADHD. Oppositional defiant disorder, uncomplicated by conduct disorder, did not predict PSUD. Family history of substance dependence and antisocial disorders was associated with PSUD in controls but less so in ADHD probands. Family history of ADHD was not associated with risk of PSUD. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<p>COMMENT. Adolescents with or without ADHD have a similar risk of psychoactive substance use disorders (PSUD), with a frequency of 15%. However, children with ADHD may be at higher risk for early-onset addictions than controls. PSUD in adolescents is associated with a history of conduct and bipolar disorders, but not oppositional defiant disorder, major depression, or anxiety disorders. The risk of PSUD is increased in adults with ADHD, and a sharp increase in PSUD may be expected in adolescent ADHD subjects as they become adults.</p>
<p><bold>Comorbid ADHD and substance abuse.</bold> Comorbidity of ADHD among adolescents in treatment for substance abuse is reported from the National Center for Post Traumatic Stress Disorder, Veteran&#x2019;s Affairs Medical Center, West Haven, CT [<xref ref-type="bibr" rid="CIT0002">2</xref>]. Attempts to self-medicate symptoms of ADHD may underlie substance use and abuse, especially in previously untreated adolescents. Prescribed medical treatment for ADHD may decrease drug craving in adults with ADHD and improve functioning.</p>
<p><bold>ADHD and cigarette smoking.</bold> ADHD, particularly when associated with conduct disorders, is a significant risk factor for early cigarette smoking in children and adolescents in a study at the Massachusetts General Hospital, Boston. [<xref ref-type="bibr" rid="CIT0003">3</xref>]</p>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biederman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wilens</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mick</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Faraone</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Curtis</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group>
<article-title>Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study</article-title>
<source>J Am Acad Child Adolesc Psychiatry</source>
<year>1997</year>
<month>Jan</month>
<volume>36</volume>
<issue>1</issue>
<fpage>21</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1097/00004583-199701000-00013</pub-id>
<pub-id pub-id-type="pmid">9000777</pub-id>
</element-citation>
</ref>
<ref id="CIT0002">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horner</surname>
<given-names>BR</given-names>
</name>
<name>
<surname>Scheibe</surname>
<given-names>KE</given-names>
</name>
</person-group>
<article-title>Prevalence and implications of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse</article-title>
<source>J Am Acad Child Adolesc Psychiatry</source>
<year>1997</year>
<month>Jan</month>
<volume>36</volume>
<fpage>30</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="doi">10.1097/00004583-199701000-00014</pub-id>
<pub-id pub-id-type="pmid">9000778</pub-id>
</element-citation>
</ref>
<ref id="CIT0003">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Milberger</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Biederman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Faraone</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>ADHD is associated with early initiation of cigarette smoking in children and adolescents</article-title>
<source>J Am Acad Child Adolesc Psychiatry</source>
<year>1997</year>
<month>Jan</month>
<volume>36</volume>
<fpage>37</fpage>
<lpage>44</lpage>
<pub-id pub-id-type="doi">10.1097/00004583-199701000-00015</pub-id>
<pub-id pub-id-type="pmid">9000779</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>